CVE-2025-12288VulnerabilityPublished 27 Oct 2025Updated 30 Oct 2025

CVE-2025-12288: Bdtask Pharmacy Management System · Authorization Bypass

Affects Bdtask Pharmacy Management SystemSource CVE Database V5

Not known to be exploited · CVSS 5.3 Medium.

Data as of 26 Oct 2026, 06:26 UTC

CVSS 4.0 base score

5.3Medium

How severe the flaw is on the 0–10 CVSS scale.

EPSS: 0.4% chance of exploitation in 30 days – higher than 40% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P

Base metrics

Attack Vector: Network
Attack Complexity: Low
Attack Requirements: None
Privileges Required: Low
User Interaction: None
Vulnerable system confidentiality: Low
Vulnerable system integrity: None
Vulnerable system availability: None
Subsequent system confidentiality: None
Subsequent system integrity: None
Subsequent system availability: None

Threat metrics

Exploit Maturity: POC

Bold values are the worst case: easiest to exploit or largest impact.

Attack Vector: Network: The vulnerable system is bound to the network stack and the set of possible attackers extends beyond the other options listed below, up to and including the entire Internet. Such a vulnerability is often termed “remotely exploitable” and can be thought of as an attack being exploitable at the protocol level one or more network hops away (e.g., across one or more routers).
Attack Complexity: Low: The attacker must take no measurable action to exploit the vulnerability. The attack requires no target-specific circumvention to exploit the vulnerability. An attacker can expect repeatable success against the vulnerable system.
Attack Requirements: None: The successful attack does not depend on the deployment and execution conditions of the vulnerable system. The attacker can expect to be able to reach the vulnerability and execute the exploit under all or most instances of the vulnerability.
Privileges Required: Low: The attacker requires privileges that provide basic capabilities that are typically limited to settings and resources owned by a single low-privileged user. Alternatively, an attacker with Low privileges has the ability to access only non-sensitive resources.
User Interaction: None: The vulnerable system can be exploited without interaction from any human user, other than the attacker.
Vulnerable system confidentiality: Low: There is some loss of confidentiality. Access to some restricted information is obtained, but the attacker does not have control over what information is obtained, or the amount or kind of loss is limited. The information disclosure does not cause a direct, serious loss to the Vulnerable System.
Vulnerable system integrity: None: There is no loss of integrity within the Vulnerable System.
Vulnerable system availability: None: There is no impact to availability within the Vulnerable System.
Subsequent system confidentiality: None: There is no loss of confidentiality within the Subsequent System or all confidentiality impact is constrained to the Vulnerable System.
Subsequent system integrity: None: There is no loss of integrity within the Subsequent System or all integrity impact is constrained to the Vulnerable System.
Subsequent system availability: None: There is no impact to availability within the Subsequent System or all availability impact is constrained to the Vulnerable System.
Exploit Maturity: POC: Based on threat intelligence sources each of the following must apply: · Proof-of-concept is publicly available · No knowledge of reported attempts to exploit this vulnerability · No knowledge of publicly available solutions used to simplify attempts to exploit the vulnerability

Definitions: FIRST CVSS v4.0 specification.

Exploitation evidence

Disclosed: evidence found.
CVE published 27 Oct 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-26.

Disclosed: The CVE record is public on cve.org. Its publication is t = 0.
Detectable: A public nuclei template can find exposed instances, for defenders and attackers alike.
Weaponised: Public exploit code exists in Metasploit or Exploit-DB, or CISA SSVC reports a public proof of concept.
Exploited in the wild: CISA KEV lists it, CISA SSVC rates exploitation active, or a source reports attacks.
Observed by OffSeq Mirage: OffSeq Mirage honeypot sensors recorded attack traffic for this CVE, or found exposed hosts without attack traffic.

Moments are spaced evenly, not to scale; a dashed line marks a gap of six months or more. Deltas count from t = 0. Sources that give only a date (CISA KEV, Exploit-DB, or a time of exactly 00:00Z) read “same day” rather than hours. Metasploit modules carry the flaw’s disclosure date, not their release date, and nuclei templates carry no date, so both appear above but not on the timeline.

What to do

Affected software

Product	Affected	Fixed in
Bdtask Pharmacy Management System	Affected =9.0 =9.1 =9.2 =9.3 =9.4	Fixed in–

AI-suggested

Since no official patches are available, European organizations should implement compensating controls immediately. These include: 1) Restricting network access to the affected /user/edit_user/ endpoint using firewalls or web application firewalls (WAFs) to limit exposure to trusted IP addresses only. 2) Enforcing strict role-based access controls (RBAC) and auditing user permissions to minimize the number of accounts with privileges to modify user profiles. 3) Monitoring logs and network traffic for unusual or unauthorized access attempts targeting the user profile management functions. 4) Employing intrusion detection/prevention systems (IDS/IPS) tuned to detect exploitation attempts of this vulnerability. 5) Isolating or segmenting the affected systems within the network to reduce lateral movement risk. 6) Preparing incident response plans specifically addressing potential exploitation scenarios. 7) Engaging with the vendor for updates and considering alternative pharmacy management solutions if remediation is delayed. 8) Conducting regular security assessments and penetration testing focused on authorization controls. These measures will help reduce the attack surface and detect exploitation attempts until a vendor patch is released.

Description

A vulnerability was detected in Bdtask Pharmacy Management System up to 9.4. Affected is an unknown function of the file /user/edit_user/ of the component User Profile Handler. Performing manipulation results in authorization bypass. Remote exploitation of the attack is possible. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Impact

For European organizations, particularly healthcare providers and pharmacies using Bdtask Pharmacy Management System, this vulnerability poses a significant risk to the confidentiality and integrity of patient and operational data. Unauthorized modification of user profiles could lead to privilege escalation, unauthorized access to sensitive medical records, or manipulation of pharmacy inventory and prescriptions. This could disrupt healthcare delivery, violate data protection regulations such as GDPR, and result in reputational damage and financial penalties. The remote exploitability and lack of required user interaction increase the likelihood of attacks. Given the critical nature of healthcare data, even a medium-severity vulnerability can have outsized consequences. Additionally, the vendor's lack of response and absence of patches prolong exposure, increasing the window of opportunity for attackers. Organizations relying on this system must consider the potential for targeted attacks aiming to disrupt healthcare services or steal sensitive data.

References

Community reviews

Loading reviews…

Exploitation evidence

What to do

Affected software

Description

AI analysisMachine-generated, updated 3 Nov 2025, 15:56 UTC

Technical details

References

Community reviews

Related threats